| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | manganese ion binding | 5.51e-04 | 71 | 10 | 2 | GO:0030145 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.97e-03 | 1189 | 10 | 4 | GO:0046914 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 4.26e-03 | 200 | 10 | 2 | GO:0008237 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.73e-03 | 211 | 10 | 2 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 8.64e-03 | 288 | 10 | 2 | GO:0016757 | |
| GeneOntologyCellularComponent | peptidase complex | 1.75e-03 | 133 | 10 | 2 | GO:1905368 | |
| MousePheno | abnormal parietal yolk sac morphology | 1.07e-04 | 177 | 8 | 3 | MP:0011203 | |
| MousePheno | abnormal trophoblast layer morphology | 1.80e-04 | 211 | 8 | 3 | MP:0005031 | |
| MousePheno | intracerebral hemorrhage | 2.68e-04 | 44 | 8 | 2 | MP:0001916 | |
| MousePheno | increased circulating creatine kinase level | 5.16e-04 | 61 | 8 | 2 | MP:0010090 | |
| MousePheno | increased creatine kinase level | 5.33e-04 | 62 | 8 | 2 | MP:0020280 | |
| MousePheno | abnormal circulating creatine kinase level | 5.85e-04 | 65 | 8 | 2 | MP:0010089 | |
| MousePheno | abnormal creatine kinase level | 6.04e-04 | 66 | 8 | 2 | MP:0020279 | |
| MousePheno | abnormal extraembryonic tissue morphology | 1.00e-03 | 908 | 8 | 4 | MP:0002086 | |
| MousePheno | intracranial hemorrhage | 1.49e-03 | 104 | 8 | 2 | MP:0001915 | |
| MousePheno | abnormal trophoblast giant cell morphology | 1.55e-03 | 106 | 8 | 2 | MP:0005033 | |
| MousePheno | abnormal mural trophectoderm morphology | 1.58e-03 | 107 | 8 | 2 | MP:0012057 | |
| Domain | - | 5.19e-03 | 207 | 10 | 2 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 6.53e-03 | 233 | 10 | 2 | IPR011990 | |
| Pubmed | 1.24e-04 | 359 | 10 | 3 | 35559673 | ||
| Pubmed | 2.72e-04 | 469 | 10 | 3 | 27634302 | ||
| Interaction | DACT2 interactions | 2.12e-05 | 16 | 9 | 2 | int:DACT2 | |
| Interaction | SPINK14 interactions | 2.12e-05 | 16 | 9 | 2 | int:SPINK14 | |
| Interaction | PPRC1 interactions | 3.71e-05 | 21 | 9 | 2 | int:PPRC1 | |
| Interaction | TINAG interactions | 6.66e-05 | 28 | 9 | 2 | int:TINAG | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.17e-06 | 186 | 10 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 5.01e-04 | 152 | 10 | 2 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-04 | 157 | 10 | 2 | f1c6c313836352271033d23efd31b0f0a8a09e02 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 5.62e-04 | 161 | 10 | 2 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 162 | 10 | 2 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 162 | 10 | 2 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.19e-04 | 169 | 10 | 2 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.19e-04 | 169 | 10 | 2 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.19e-04 | 169 | 10 | 2 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.33e-04 | 171 | 10 | 2 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 171 | 10 | 2 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-04 | 172 | 10 | 2 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-04 | 172 | 10 | 2 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-04 | 176 | 10 | 2 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-04 | 177 | 10 | 2 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-04 | 178 | 10 | 2 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-04 | 179 | 10 | 2 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 181 | 10 | 2 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-04 | 181 | 10 | 2 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-04 | 184 | 10 | 2 | 8b397f9c18ed7abecdbcbd586d0ddadf07cf6e75 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.33e-04 | 184 | 10 | 2 | 300edc4aa3ce55f309005c02c315fa0102ea9da7 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 7.41e-04 | 185 | 10 | 2 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.41e-04 | 185 | 10 | 2 | a86a3a1a187a4d8d7762bc6d3dcb22c982178d22 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.48e-04 | 186 | 10 | 2 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.65e-04 | 188 | 10 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 368C-Lymphocytic-B_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-04 | 190 | 10 | 2 | b9abf773525f7bbc87b8c0d4e94e9d18017de82b | |
| ToppCell | 368C-Lymphocytic-B_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-04 | 190 | 10 | 2 | 1a016ae2603be5d024ba024faafd725787db8c48 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.89e-04 | 191 | 10 | 2 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.97e-04 | 192 | 10 | 2 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.05e-04 | 193 | 10 | 2 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.05e-04 | 193 | 10 | 2 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.05e-04 | 193 | 10 | 2 | 8f8d2006fb40a207c743cfd2e9a9f47c2bac1eea | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 8.05e-04 | 193 | 10 | 2 | 2ffe44edf2b02d11a7c10513692eb697a10f911e | |
| ToppCell | Control-Treg|Control / Disease condition and Cell class | 8.22e-04 | 195 | 10 | 2 | bbe9789eb2c17f43de55b2e6d01d1093c64dc666 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.30e-04 | 196 | 10 | 2 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-04 | 196 | 10 | 2 | 85684b881655e47f06f0cf00721183825fa00913 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-04 | 196 | 10 | 2 | e38036a5dbaed1488e01616bdc7678b28968470b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.47e-04 | 198 | 10 | 2 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.47e-04 | 198 | 10 | 2 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-04 | 198 | 10 | 2 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.64e-04 | 200 | 10 | 2 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.64e-04 | 200 | 10 | 2 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.64e-04 | 200 | 10 | 2 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.64e-04 | 200 | 10 | 2 | bc7aba2885ca1093fcd884807b497700dae4835e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| Computational | Neighborhood of MSH2 | 4.68e-04 | 61 | 6 | 2 | MORF_MSH2 | |
| Disease | Global developmental delay | 8.86e-04 | 133 | 10 | 2 | C0557874 | |
| Disease | Seizures | 2.35e-03 | 218 | 10 | 2 | C0036572 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AKIPLGFYYGHTYIL | 1871 | Q9NR09 | |
| LDYSLYHHLAGYKGV | 1256 | Q96PN6 | |
| HSYGQLILTPYGYTK | 236 | Q8IVL8 | |
| PSGTKILYHGYSLLY | 1461 | P02462 | |
| HPLYHYKTYVGGILL | 191 | Q9UBV7 | |
| THLPLYHYEKGLFNY | 356 | Q9Y6W6 | |
| RGYTSKIAGILHYYP | 431 | P14735 | |
| LAHIYHYYIHGPKGN | 346 | A6NHR9 | |
| LHFKHIYLYVAPAYG | 196 | Q9BVK2 | |
| LYIRGHNGKIYPYLV | 3516 | Q9Y4A5 |